Fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography scan contributes to the diagnosis and management of brucellar spondylodiskitis

BMC Infectious Diseases

Nikolaos V Sipsas¹  Alexandra Zormpala²  Spiros G Pneumaticos³  Sofia Chatziioannou⁴  Savvas Ioannou¹ 

[1] Pathophysiology Department, Medical School, National and Kapodistrian University of Athens, 75, Mikras Asias, 115 27, Athens, Greece;Radiology Department, Laikon General Hospital, and Medical School, National and Kapodistrian University of Athens, Athens, Greece;Department of Orthopaedics, KAT General Hospital, and Medical School, National and Kapodistrian University of Athens, Athens, Greece;Department of Radiology, Center for Clinical Research, Nuclear medicine and PET/CT Section, Foundation for Biomedical Research of the Academy of Athens, Athens, Greece

关键词: Standardized uptake value;    Positron emission tomography;    Spondylodiskitis;    Brucella;   

Others  :  1158432
DOI  :  10.1186/1471-2334-13-73

 received in 2012-08-20, accepted in 2013-01-28,  发布年份 2013

【 摘 要 】

Background

Limited data suggest that fluorine-18 fluoro-2-deoxy-D-glucose (F-18 FDG) positron emission tomography combined with computed tomography (PET/CT) scan may be useful for diagnosing infections of the spine. Brucellar spondylodiskitis might be devastating and current imaging techniques lack sensitivity and specificity. The aim of this prospective study was to determine the role of F-18 FDG PET/CT scan in the diagnosis of brucellar spondylodiskitis and in monitoring the efficacy of its treatment.

Methods

Ten consecutive patients with brucellar spondylitis were prospectively evaluated with PET/CT. Baseline evaluation included also magnetic resonance imaging (MRI) of the affected spine, indices of inflammation, the slide agglutination test (SAT), and the standard hematology and biochemistry. All cases were treated with suitable antibiotics until resolution or significant improvement of clinical and radiological (MRI) findings. Upon completion of treatment, they were re-evaluated with follow-up PET/CT scan. The maximum standardized uptake values (SUV) were measured and compared with SAT.

Results

In all patients there was an increased F-18 FDG activity in the infected spine region detected by the initial MRI. F-18 FDG PET/CT provided additional information, compared to MRI, in 4 (40%) patients. More specifically it revealed additional spine lesions (in 3 patients), lymphadenitis, arthritis, organomegaly, as well as new paravertebral soft tissue involvement and epidural masses. This additional information had an impact on the duration of treatment in these patients. At the end of treatment all patients had a complete clinical response; 5 patients had positive serology, 6 patients had residual MRI findings, while 9 had a positive PET/CT but with significantly decreased FDG uptake compared to baseline (median 2.6, range 1.4 – 4.4 vs. median 5.5, range 2.8 – 9.4, p = 0.005). During the follow up period (median 12.5 months) no relapses have been observed. No significant association was observed between the SUV and SAT.

Conclusions

Our study suggests that in patients with brucellar spondylodiskitis F-18 FDG PET/CT scan can provide additional information on the spread of the infection, compared to MRI. Successful treatment is associated with a significant decrease in SUVmax values; thus, PET/CT scan may be a complementary method for determining the efficacy of treatment.

【 授权许可】

   
2013 Ioannou et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Namiduru M, Karaoglan I, Gursoy S, Bayazit N, Sirikci A: Brucellosis of the spine: evaluation of the clinical, laboratory, and radiological findings of 14 patients. Rheumatol Int 2004, 24:125-129.
• [2]Solera J, Lozano E, Martinez-Alfaro E, Espinosa A, Castillejos ML, Abad L: Brucellar spondylitis: review of 35 cases and literature survey. Clin Infect Dis 1999, 29:1440-1449.
• [3]Kulowski J, Vinke TH: Undulant (Malta) fever spondylitis: report of a case due to Brucella melitensis, bovine variety, surgically treated. JAMA 1932, 99:1656-1659.
• [4]Gratz S, Dörner J, Fischer U, Behr TM, Béhé M, Altenvoerde G, Meller J, Grabbe E, Becker W: 18 F-FDG hybrid PET in patients with suspected spondylitis. Eur J Nucl Med Mol Imaging 2002, 29:516-524.
• [5]Gemmel F, Dumarey N, Palestro CJ: Radionuclide imaging of spinal infections. Eur J Nucl Med Mol Imaging 2006, 33:1226-1237.
• [6]Longo M, Granata F, Ricciardi K, Gaeta M, Blandino A: Contrast-enhanced MR imaging with fat suppression in adult-onset septic spondylodiscitis. Eur Radiol 2003, 13:626-637.
• [7]Kälicke T, Schmitz A, Risse JH, Arens S, Keller E, Hansis M, Schmitt O, Biersack HJ, Grünwald F: Fluorine-18 fluorodeoxyglucose PET in infectious bone diseases: results of histologically confirmed cases. Eur J Nucl Med 2000, 27:524-528.
• [8]Lee IS, Lee JS, Kim SJ, Jun S, Suh KT: Fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography imaging in pyogenic and tuberculous spondylitis: preliminary study. J Comput Assist Tomogr 2009, 33:587-592.
• [9]Gemmel F, Rijk PC, Collins JM, Parlevliet T, Stumpe KD, Palestro CJ: Expanding role of 18 F-fluoro-D-deoxyglucose PET and PET/CT in spinal infections. Eur Spine J 2010, 19:540-551.
• [10]Maiuri F, Iaconetta G, Gallicchio B, Manto A, Briganti F: Spondylodiscitis. Clinical and magnetic resonance diagnosis. Spine (Phila Pa 1976) 1997, 22:1741-1746.
• [11]Ioannou S, Karadima D, Pneumaticos S, Athanasiou H, Pontikis J, Zormpala A, Sipsas NV: Efficacy of prolonged antimicrobial chemotherapy for brucellar spondylodiscitis. Clin Microbiol Infect 2011, 17:756-762.
• [12]Alp E, Koc RK, Durak AC, Yildiz O, Aygen B, Sumerkan B, Doganay M: Doxycycline plus streptomycin versus ciprofloxacin plus rifampicin in spinal brucellosis. BMC Infect Dis 2006, 6:72. BioMed Central Full Text
• [13]Schmitz A, Kälicke T, Willkomm P, Grünwald F, Kandyba J, Schmitt O: Use of fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in assessing the process of tuberculous spondylitis. J Spinal Disord 2000, 13:541-544.
• [14]Vanninen E, Laitinen T, Partanen K, Tulla H, Herno A, Kröger H: Late correlative imaging findings of previous acute infective spondylitis. Clin Nucl Med 2000, 25:779-784.
• [15]Van der Bruggen W, Bleeker-Rovers CP, Boerman OC, Gotthardt M, Oyen WJ: PET and SPECT in osteomyelitis and prosthetic bone and joint infections: a systematic review. Semin Nucl Med 2010, 40:3-15.
• [16]Ito K, Kubota K, Morooka M, Hasuo K, Kuroki H, Mimori A: Clinical impact of (18)F-FDG PET/CT on the management and diagnosis of infectious spondylitis. Nucl Med Commun 2010, 31:691-698.
• [17]Zormpala A, Skopelitis E, Thanos L, Artinopoulos C, Kordossis T, Sipsas NV: An unusual case of brucellar spondylitis involving both the cervical and lumbar spine. Clin Imaging 2000, 24:273-275.
• [18]Schmitz A, Risse JH, Grünwald F, Gassel F, Biersack HJ, Schmitt O: Fluorine-18 fluorodeoxyglucose positron emission tomography findings in spondylodiscitis: preliminary results. Eur Spine J 2001, 10:534-539.
• [19]Stumpe KD, Zanetti M, Weishaupt D, Hodler J, Boos N, Von Schulthess GK: FDG positron emission tomography for differentiation of degenerative and infectious endplate abnormalities in the lumbar spine detected on MR imaging. AJR Am J Roentgenol 2002, 179:1151-1157.
• [20]Rosen RS, Fayad L, Wahl RL: Increased 18 F-FDG uptake in degenerative disease of the spine: characterization with 18 F-FDG PET/CT. J Nucl Med 2006, 47:1274-1280.
• [21]Harman M, Unal O, Onbaşi KT, Kiymaz N, Arslan H: Brucellar spondylodiscitis: MRI diagnosis. Clin Imaging 2001, 25:421-427.
• [22]Navarro E, Segura JC, Castaño MJ, Solera J: Use of real-time quantitative polymerase chain reaction to monitor the evolution of Brucella melitensis DNA load during therapy and post-therapy follow-up in patients with brucellosis. Clin Infect Dis 2006, 42:1266-1273.
• [23]Vrioni G, Pappas G, Priavali E, Gartzonika C, Levidiotou S: An eternal microbe: Brucella DNA load persists for years after clinical cure. Clin Infect Dis 2008, 46:e131-e136.